STAAR Surgical Announces Strategic Alliance Agreement with Dr. Tobias Neuhann in Germany

STAAR Surgical (NASDAQ:STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced a multi-year Strategic Alliance Agreement with Dr. Tobias Neuhann of the Augenklinik am Marienplatz (Eye Clinic at Marienplatz) in Munich, Germany.

As quoted in the press release:

 The agreement serves as a global partnership model for smaller and single site refractive surgery eye clinics that aim to provide STAAR’s EVO Visian ICL™ intraocular lenses as a primary and premium option for patients seeking visual freedom from spectacles and contact lenses.

Caren Mason, President & CEO of STAAR, stated, “Our agreement with Dr. Tobias Neuhann highlights the collaborative excellence possible between STAAR and ophthalmologists operating clinics outside large hospital, university and multi-site settings. Offering many of the benefits of our larger strategic cooperation agreements to these clinics is an important component of STAAR’s growth strategy. Dr. Neuhann is a pioneer with a long history of excellence working with the ICL including our latest generation of the EVO family of lenses. His passion for the ICL is shared by his family. His son, Raphael Neuhann, is on staff at Augenklinik am Marienplatz as a dedicated ICL surgeon. The family also loves sailing and sails a Flying Phantom catamaran as part of an EVO Visian ICL branded sailing team. The catamaran prominently features EVO as part of STAAR’s ‘Break Free From Glasses’ campaign and illustrates one aspect of our company’s creative approach to marketing with our ophthalmology customers. We are thrilled to formally expand our collaboration with this highly-regarded doctor and his family’s clinic.”

Click here to read the full press release.